RANIERI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 5.365
EU - Europa 4.971
AS - Asia 1.741
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 8
OC - Oceania 5
AF - Africa 2
Totale 12.104
Nazione #
US - Stati Uniti d'America 5.345
IE - Irlanda 1.644
CN - Cina 1.237
UA - Ucraina 1.091
SE - Svezia 844
IT - Italia 557
FR - Francia 261
IN - India 238
TR - Turchia 233
FI - Finlandia 202
DE - Germania 178
GB - Regno Unito 94
BE - Belgio 27
RU - Federazione Russa 21
CA - Canada 20
CZ - Repubblica Ceca 20
NL - Olanda 15
SG - Singapore 11
EU - Europa 9
CL - Cile 7
ES - Italia 7
IR - Iran 6
JP - Giappone 6
RO - Romania 5
IL - Israele 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HK - Hong Kong 3
NZ - Nuova Zelanda 3
AU - Australia 2
PL - Polonia 2
ZA - Sudafrica 2
AT - Austria 1
BR - Brasile 1
GR - Grecia 1
LU - Lussemburgo 1
MN - Mongolia 1
PH - Filippine 1
TH - Thailandia 1
Totale 12.104
Città #
Dublin 1.644
Chandler 999
Jacksonville 772
Nyköping 548
Dearborn 541
Nanjing 378
Wilmington 239
Ashburn 202
New York 200
Princeton 179
San Mateo 157
Nanchang 145
Beijing 134
Ann Arbor 122
Boardman 117
Foggia 95
Shenyang 84
Woodbridge 83
Des Moines 72
Hebei 68
Tianjin 68
Helsinki 62
Kunming 51
Seattle 50
Munich 46
Changsha 41
Pune 36
Bari 35
Hangzhou 31
Jiaxing 31
Jinan 30
Falls Church 29
Brussels 25
Hilden 25
Rome 25
Zhengzhou 24
Milan 22
Ningbo 22
Augusta 19
Brno 17
Noci 17
Norwalk 17
Changchun 16
Lanzhou 16
Stevenage 15
Los Angeles 14
Taizhou 14
Toronto 14
Auburn Hills 13
Fuzhou 13
Houston 12
Guangzhou 11
Saint Petersburg 10
Singapore 10
Leawood 9
Orange 9
Rotterdam 9
San Francisco 9
Shanghai 9
Latina 8
Molfetta 8
Redwood City 8
Acquaviva Delle Fonti 7
Bisceglie 7
Florence 7
Washington 7
Fairfield 6
Hefei 6
Kocaeli 6
Catania 5
Paris 5
Rockville 5
San Severo 5
Tappahannock 5
Bologna 4
Borås 4
Fremont 4
Haikou 4
Mountain View 4
Palese 4
Pesaro 4
Redmond 4
Torremaggiore 4
Ardabil 3
Avigliano 3
Bergamo 3
Bitonto 3
Chicago 3
Jerusalem 3
London 3
Philadelphia 3
Phoenix 3
Shaoxing 3
Taiyuan 3
Tokyo 3
Trani 3
Valencia 3
Abbiategrasso 2
Altamura 2
Ariccia 2
Totale 7.884
Nome #
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 198
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 176
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 128
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 127
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 124
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 118
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 115
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 113
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 112
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 112
cell carcinoma cell line and use thereof. 109
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 107
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 104
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 103
IgA nephropathy: pros and cons for a familial disease. 102
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 100
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 99
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 97
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 96
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 96
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 96
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 94
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 94
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 93
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 93
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 92
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 91
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 91
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 90
Renal Carcinoma Cell Line and Use Thereof 90
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 90
Renal cortical complement C3 gene expression in IgA nephropathy 89
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 89
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 88
Biosimilar: can we manage biopharmaceutical heterogeneity? 87
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 87
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 85
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 85
Reclassification of glomerulopathies: which role for the podocyte? 85
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 85
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 85
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 83
Immunologic Response to RCC. 82
Urinary epidermal growth factor concentration in patients affected by ADPKD. 82
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 82
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 82
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 81
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 81
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 81
Linea cellulare di carcinoma renale e suo uso 81
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 80
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 80
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 80
Renal and upper urinary tract tumors: what the nephrologist should know 79
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 79
Growth factors and their receptors in the progression of renal damage. 79
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 79
Is Berger's disease a hereditary nephritis? 78
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 78
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 78
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 77
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 77
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 77
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 76
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 75
Cytotoxic T-Cells Methods and Protocols Preface 75
TLR7 and TLR8 as targets for tumor immunotherapy 74
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 73
Platelet-derived growth factor and proliferative glomerulonephritis. 72
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 72
Diagnostic and prognostic markers of renal cell carcinoma 72
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 71
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 71
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 71
Altered expression of the clock gene machinery in kidney cancer patients 71
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 71
Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: Description of an optimized gel-based protocol 71
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 70
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 70
Salivary proteomic signatures of oral squamous cell carcinoma. 70
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 70
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 69
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 69
Monitoring biological action of rapamycin in renal transplantation. 69
Profiles of immunoregolatory cytokine production in vitro in patients with IgA nephropathy and their kindred 69
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA) 69
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 68
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 68
TGF-β promotes immune suppression by inhibiting Treg cell apoptosis 67
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 67
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression 67
Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. 67
Diabetes Mellitus (DM) reduces survival in patients with renal cell carcinoma (RCC) : role of OGG1 and tuberine 67
Current insights in renal cell cancer pathology 66
PROTEOMIC PROFILE OF CD24+CD133+RENAL MULTIPOTENT PROGENITORS (RMP) 66
CTL ELISPOT AssayCytotoxic T-Cells 66
Expression of transforming growth factor-beta 1 in thyroid tumor 65
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 65
Thrombin modulate T cells response induced by dendritic cells (DC) in kidney transplant recipients with delayed graft function (DGF) 65
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 64
Totale 8.539
Categoria #
all - tutte 58.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.271


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019174 0 0 0 0 0 0 0 0 0 0 0 174
2019/20202.537 502 313 106 38 308 329 397 76 207 33 206 22
2020/20211.547 179 5 167 58 180 114 222 43 295 263 17 4
2021/20221.139 157 14 16 33 119 46 41 79 187 139 39 269
2022/20234.250 372 177 237 274 257 365 42 312 1.957 54 88 115
2023/2024931 120 34 49 23 73 387 58 87 17 14 14 55
Totale 12.557